N
Norman R. Farnsworth
Researcher at University of Illinois at Chicago
Publications - 302
Citations - 22801
Norman R. Farnsworth is an academic researcher from University of Illinois at Chicago. The author has contributed to research in topics: Black cohosh & Epidermoid carcinoma. The author has an hindex of 62, co-authored 302 publications receiving 21485 citations. Previous affiliations of Norman R. Farnsworth include Ohio State University & Mahidol University.
Papers
More filters
Journal ArticleDOI
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
Mei-Shiang Jang,Lining Cai,George Udeani,Karla Slowing,Cathy F. Thomas,Chris Beecher,Harry H. S. Fong,Norman R. Farnsworth,A. Douglas Kinghorn,Rajendra G. Mehta,Richard C. Moon,John M. Pezzuto +11 more
TL;DR: It is suggested that resveratrol, a common constituent of the human diet, merits investigation as a potential cancer chemopreventive agent in humans.
Journal ArticleDOI
The value of plants used in traditional medicine for drug discovery.
TL;DR: This review describes and discusses several approaches to selecting higher plants as candidates for drug development with the greatest possibility of success and identifies and discusses advantages and disadvantages of using plants as starting points for drugDevelopment, specifically those used in traditional medicine.
Journal ArticleDOI
Medicinal plants in therapy.
TL;DR: This update article presents a list of plant-derived drugs, with the names of the plant sources, and their actions or uses in therapy.
Journal ArticleDOI
Antidiabetic plants and their active constituents.
TL;DR: This review provides information on more than 1200 species of plants reported to have been used to treat diabetes and/or investigated for antidiabetic activity, with a detailed review of representative plants and some of great diversity of plant constituents with hypoglycemic activity.
Journal ArticleDOI
Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis
E. Pisha,Heebyung Chai,Ik-Soo Lee,T E Chagwedera,Norman R. Farnsworth,Geoffrey A. Cordell,Chris Beecher,Harry H. S. Fong,A. D. Kinghorn,David M. Brown,David M. Brown +10 more
TL;DR: As a result of bioassay–guided fractionation, betulinic acid, a pentacyclic triterpene, was identified as a melanoma–specific cytotoxic agent and antitumour activity was mediated by the induction of apoptosis.